China ChemPharm Annual Summit for 2016 was successfully held in Wuhan, Hubei on November 15. The List of “Outstanding Enterprises and Outstanding Product Brands in the Chemical Pharmaceutical Industry in China for 2016” recommended by CPIA (China Pharmaceutical Industry Association), CAPC (China Association of Pharmaceutical Commerce), CNMA (China Nonprescription Medicines Association), CPEP (China Pharmaceutical Enterprises Development Promote Association) and RSE (Reed Sinopharm Exhibitions Co., Ltd.) was released at the meeting. The list includes 28 awards in 4 sectors, such as 10 Top Enterprise Groups in China's Pharmaceutical Industry for 2016, Outstanding Enterprise Brands in Chemical Pharmaceutical Industry in China for 2016, Outstanding Product Brands in Chemical Pharmaceutical Industry in China and Special Awards for 2016. More than 100 famous domestic pharmaceutical enterprises with good business results, brand competitiveness and outstanding performance in new drug R&D and innovation in 2015 were recognized.
Hansoh Pharma ranked:
No. 9 among the 100 Top Industrial Enterprises in Terms of Comprehensive Strength in the Chemical Pharmaceutical Industry in China for 2016
No. 6 among the Innovative Outstanding Enterprise Brands in the Chemical Pharmaceutical Industry in China for 2016
No. 2 among the Outstanding Enterprise Brands for Promoting Integration of Informatization and Industrialization in the Chemical Pharmaceutical Industry in China for 2016
Eight products of Hansoh Pharma were included into the List of “Outstanding Product Brands in Chemical Pharmaceutical Industry in China for 2016”
It is worth noting that, with its innovative national class 1.1 medicine, Mailingda (Morinidazole Sodium Chloride Injection), Hansoh Pharma was the only winner of the Special Award for Innovative Medicine in the Chemical Pharmaceutical Industry in China for 2016. It is a powerful testament to the Company’s leading R&D capacity for innovative medicine.
Six consecutive sessions of China ChemPharm Annual Summit have been held since 2011. A forum session on the themes of “quality, integrity and brands” was organized at this year’s summit, covering interpretation of relevant policies, analysis of the economic situation facing the pharmaceutical industry, construction of the drug tracking system and release of credit evaluation results for pharmaceutical enterprises. It was a great event featuring the most comprehensive and deep communication in the chemical pharmaceutical industry, with the aim of promoting industry brand building, enhancing awareness among enterprises of “product quality and social responsibility”, and driving the stable and healthy development of enterprises.
